Reimbursements Clause Example with 25 Variations from Business Contracts
This page contains Reimbursements clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 Exhibit 10.17 ULTHERA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee mem...bers of the board of directors (the "Board") of Ulthera, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being adopted pursuant to the Board's resolutions on April 25, 2014. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become effective on the date of the closing of the initial public offering of Company common stock (the "Effective Date").View More
Variations of a "Reimbursements" Clause from Business Contracts
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 EX-10.26 11 d662886dex1017.htm EX-10.17 EX-10.17 d179389dex1026.htm EX-10.26 EX-10.26 Exhibit 10.17 ULTHERA, 10.26 E.L.F. BEAUT...Y, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, e.l.f. Beauty, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being adopted pursuant to the Board's resolutions on April 25, 2014. "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not (i) an employee of the Company or any parent or subsidiary of the Company Company, (ii) a partner, member, director, officer or employee of TPG Growth II Management, LLC (or any other entity which, directly or indirectly, through one or more intermediaries, is controlled by or under common control with such entity, whether by contract, equity ownership or otherwise) or (iii) designated for service on the Board by the Rollover Stockholders (as defined in that certain Amended and Restated Stockholders Agreement, dated on or about the Effective Date (as defined below), by and among the Company, TPG elf Holdings, L.P., the Rollover Stockholders and the other parties thereto, as the same may be amended from time to time) (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, Director"), unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time time, without advance notice, in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become effective on the date of the closing pricing of the initial public offering of Company the Company's common stock (the "Effective Date"). View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 Exhibit 10.17 ULTHERA, A Name Number of Shares Clay Siegall 180,000 Larry Alleva 108,00...0 Michael Powell 108,000 Edward Mathers 108,000 Elaine Jones 108,000 Matt Winkler 108,000 Total: 720,000 4 EX-10.11 17 a2225898zex-10_11.htm EX-10.11 Exhibit 10.11 MIRNA THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Mirna Therapeutics, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being adopted pursuant to the Board's resolutions on April 25, 2014. August 31, 2015. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time time, without advance notice, in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become effective on the date of the closing pricing of the initial public offering of Company common stock (the "Effective Date"). View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 US-DOCS\123809590.2 EX-10.1 2 crnx-ex101_251.htm EX-10.1 crnx-ex101_251.htm Exhibit 10....17 ULTHERA, INC. NON-EMPLOYEE 10.1 CRINETICS PHARMACEUTICALS, Inc. Non-Employee DIRECTOR COMPENSATION PROGRAM As Amended Effective March 16, 2021 Non-employee members of the board of directors (the "Board") of Ulthera, Crinetics Pharmaceuticals, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant to under the Board's resolutions Company's 2018 Incentive Award Plan (the "Equity Plan") and shall be effective on April 25, 2014. March 16, 2021. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program No Non-Employee Director shall become effective on have any rights hereunder, except with respect to stock options granted pursuant to the date of Program. Capitalized terms not otherwise defined herein shall have the closing of meanings ascribed in the initial public offering of Company common stock (the "Effective Date"). Equity Plan. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.8 15 d808052dex108.htm EX-10.8 EX-10.8 Exhibit 10.17 ULTHERA, 10.8 EARGO, INC. NO...N-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Eargo, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being adopted pursuant to the Board's resolutions on April 25, 2014. "Program") effective as of [_______] (the "Effective Date"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become Directors effective on the date as of the closing of the initial public offering of Company common stock (the "Effective Date"). Effective Date. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.3 9 d827765dex103.htm EX-10.3 EX-10.3 Exhibit 10.17 ULTHERA, 10.3 ZENTALIS PHARMA...CEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM PROGRAM* Non-employee members of the board of directors (the "Board") of Ulthera, Zentalis Pharmaceuticals, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant under the Company's 2020 Incentive Award Plan (the "Equity Plan") and shall be effective on the pricing date of the Company's initial public offering (the "IPO") of the Company's common stock (and immediately following the Company's corporate conversion to be effected in accordance with such IPO but prior to the Board's resolutions effectiveness of the Company's Registration Statement on April 25, 2014. S-1 filed with the Securities and Exchange Commission in connection with the IPO) (the "Effective Date"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program No Non-Employee Director shall become effective on have any rights hereunder, except with respect to stock options granted pursuant to the date of Program. Capitalized terms not otherwise defined herein shall have the closing of meanings ascribed in the initial public offering of Company common stock (the "Effective Date"). Equity Plan. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 Exhibit A Name Number of Shares Clay Siegall 12,000 Larry Alleva 10,533 Michael Powell 7,200 Edward Mathers 7,200 Elaine Jones ...7,200 Matt Winkler 7,200 Total: 51,333 4 EX-10.11 11 d662886dex1017.htm EX-10.17 EX-10.17 a2226006zex-10_11.htm EX-10.11 Exhibit 10.17 ULTHERA, 10.11 MIRNA THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM PROGRAM* Non-employee members of the board of directors (the "Board") of Ulthera, Mirna Therapeutics, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being adopted pursuant to the Board's resolutions on April 25, 2014. August 31, 2015. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time time, without advance notice, in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become effective on the date of the closing pricing of the initial public offering of Company common stock (the "Effective Date"). View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 Exhibit 10.17 ULTHERA, EX-10.4 5 lmfa-ex10_4.htm EX-10.4 EX-10.4 Exhbit 10.4 LM FUNDING... AMERICA, INC. NON-EMPLOYEE Non-Employee DIRECTOR COMPENSATION PROGRAM (Amended and Effective November 18, 2022) Non-employee members of the board of directors (the "Board") of Ulthera, LM Funding America, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant to under the Board's resolutions on April 25, 2014. Company's 2021 Omnibus Incentive Plan (the "Equity Plan"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program No Non-Employee Director shall become effective on have any rights hereunder, except with respect to equity awards to be automatically granted pursuant to the date of Program. Capitalized terms not otherwise defined herein shall have the closing of meanings ascribed in the initial public offering of Company common stock (the "Effective Date"). Equity Plan. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures procedures, as in effect from time to time. To the extent that any reimbursement under the this Program provides for a deferral of compensation under Section 409A of the Internal R...evenue Code of 1986, as amended: (a) the amount eligible for reimbursement in one calendar year may not affect the amount eligible for reimbursement in any other calendar year; (b) the right to reimbursement is not subject to liquidation or exchange for another benefit; and (c) any such reimbursement of an expense must be made on or before the last day of the calendar year following the calendar year in which the expense was incurred. * * * * * 3 EX-10.17 EX-10.26 11 d662886dex1017.htm EX-10.17 EX-10.17 d629509dex1026.htm EX-10.26 EX-10.26 Exhibit 10.17 ULTHERA, 10.26 AKEBIA THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Akebia Therapeutics, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being adopted pursuant to the Board's resolutions on April 25, February 28, 2014. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program shall be reviewed by the Board periodically and may be amended, modified or terminated by the Board at any time in its sole discretion. discretion and nothing herein should be construed as a guarantee to any Non-Employee Director of any particular level of cash or equity compensation. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become effective on the date of the closing of the initial public offering of Company common stock (the "Effective Date"). View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.16 40 d524894dex1016.htm EX-10.16 EX-10.16 Exhibit 10.17 ULTHERA, 10.16 INTUITY M...EDICAL, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Ulthera, Intuity Medical, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being adopted pursuant to the Board's resolutions on April 25, 2014. "Program") effective as of [_______] (the "Effective Date"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program shall become Directors effective on the date as of the closing of the initial public offering of Company common stock (the "Effective Date"). Effective Date. View More
Reimbursements. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company's applicable expense reimbursement policies and procedures as in effect from time to time. * * * * * 3 EX-10.17 11 d662886dex1017.htm EX-10.17 EX-10.17 EX-10.5 5 phat-ex10_5.htm EX-10.5 EX-10.5 Exhibit 10.17 ULTHERA, 10.5 PHATHOM PHARMACEU...TICALS, INC. NON-EMPLOYEE AMENDED AND RESTATED Non-Employee DIRECTOR COMPENSATION PROGRAM (effective as of May 25, 2022) Non-employee members of the board of directors (the "Board") of Ulthera, Phathom Pharmaceuticals, Inc. (the "Company") shall be eligible to receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"), which is being "Program"). This Program has been adopted pursuant to under the Board's resolutions Company's 2019 Incentive Award Plan (the "Equity Plan") and shall be effective on April 25, 2014. the Effective Date. The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who may be eligible is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. This Program No Non-Employee Director shall become effective on have any rights hereunder, except with respect to stock options granted pursuant to the date of Program. Capitalized terms not otherwise defined herein shall have the closing of meanings ascribed in the initial public offering of Company common stock (the "Effective Date"). Equity Plan. View More
